Showing results (211-220 of 256) with videos related to

Sort By:
Pageof 26
Arthritis Research & Therapy|May 21, 2010
Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritisMelek Güler-Yüksel, Naomi B Klarenbeek, Yvonne P M Goekoop-Ruiterman, et al.
Arthritis and Rheumatism|September 18, 2003
Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trialZuzana de Jong, Marten Munneke, Aeilko H Zwinderman, et al.
Annals of the Rheumatic Diseases|April 14, 2009
Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort studyW H Bos, G J Wolbink, M Boers, et al.
Arthritis Research & Therapy|April 5, 2012
Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot studyStefan T G Bruijnen, Mignon A C van der Weijden, Joannes P Klein, et al.
Annals of the Rheumatic Diseases|November 11, 2010
The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgiaLotte A van de Stadt, Ann R van der Horst, Margret H M T de Koning, et al.
Annals of the Rheumatic Diseases|January 22, 2009
DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritisY P M Goekoop-Ruiterman, J K de Vries-Bouwstra, P J S M Kerstens, et al.
Annals of the Rheumatic Diseases|February 23, 2007
Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritisM J L Peters, M Vis, V P van Halm, et al.
Annals of the Rheumatic Diseases|July 9, 2010
Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximabN B Klarenbeek, M Güler-Yüksel, D M F M van der Heijde, et al.
Annals of the Rheumatic Diseases|October 22, 2008
Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritisS M van der Kooij, S le Cessie, Y P M Goekoop-Ruiterman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 12, 2012
Inactivating PSMB5 mutations and P-glycoprotein (multidrug resistance-associated protein/ATP-binding cassette B1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno)proteasome inhibitors in mononuclear blood cells from patients with rheumatoid arthritisSue Ellen Verbrugge, Yehuda G Assaraf, Ben A C Dijkmans, et al.
Pageof 26